REC-3964

N/A

Report date: 2025/06/13 20:00:59
NME

Base Information

Drug NameREC-3964
Drug Alias NameREC-3964
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCeramide glucosyltransferase inhibitors
TargetsCeramide glucosyltransferase
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRecursion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecursion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A